EGRX

Eagle Pharmaceuticals, Inc.

Delisted

EGRX was delisted on the 2nd of October, 2024.

27 hedge funds and large institutions have $37.6M invested in Eagle Pharmaceuticals, Inc. in 2014 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
27
Holders Change
-1
Holders Change %
-3.57%
% of All Funds
0.78%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
7
Reduced
4
Closed
10
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
PCM
26
Prelude Capital Management
New York
$1K +$1K +100 New
Northern Trust
27
Northern Trust
Illinois
-$444K -31,024 Closed
PP
28
Paloma Partners
Connecticut
-$206K -14,363 Closed
Bank of America
29
Bank of America
North Carolina
-$173K -12,076 Closed
Deutsche Bank
30
Deutsche Bank
Germany
-$142K -9,985 Closed
PAM
31
Paradigm Asset Management
New York
-$90.3K -6,300 Closed
BA
32
BlackRock Advisors
Delaware
-$22K -1,570 Closed
PSC
33
Piper Sandler & Co
Minnesota
-$18K -1,277 Closed
BJ
34
BlackRock Japan
Japan
-$7K -508 Closed
Wells Fargo
35
Wells Fargo
California
-$7K -500 Closed
GSC
36
Ground Swell Capital
South Carolina
-$6K -400 Closed